OpenLB
Open Library of Bioscience
Advanced Search
Nature biotechnology
Dec, 1998;16 (13): 1371-2.

Negotiating the maze of biotech "tool patents".

D Mascarenhas
Author Information
  1. D Mascarenhas: Celtrix Pharmaceuticals, Santa Clara, CA 95054-1815, USA. desmond@celtrix.com
PMID: 9853622 DOI: 10.1038/4357

Abstract

Circumventing existing patents may be a shortcut to getting your recombinant protein to market.

MeSH Term

Biotechnology
Negotiating
Patents as Topic
Recombinant Proteins

Chemicals

Recombinant Proteins
Journal Article
Article has an altmetric score of 3

Word Cloud

Created with Highcharts 10.0.0CircumventingexistingpatentsmayshortcutgettingrecombinantproteinmarketNegotiatingmazebiotech"toolpatents"

Similar Articles

Cited By

No available data.